Is preoperative colonoscopy in all gynecologic cancer patients necessary?

Objective: The aim of this study was to evaluate the necessity of preoperative colonoscopy in gynecologic cancer patients. Material and Methods: Retrospectively, patients diagnosed with gynecologic can- cers and undergoing preoperative colonoscopy between January 2013 and April 2020 in Zonguldak Bülent Ecevit University were included in the study, and their in- formation was recorded. Results: A total of 186 patients with gynecologic cancers were included in the study. Of these, 64 (35%) were less than 50 years of age, and 122 (65%) were 50 years or older. The mean age was 58.83±14.20 years (min: 31, max: 85). In the study, 96 (51.6%) of the patients had endometrial cancer, 54 (29%) had ovarian cancer, 34 (18.3%) had uterine-cervix cancer, and 2 (1.1%) patients had vulvar cancer. Extrinsic compression in 18 (9.7%), colonic polyps in 16 (8.6%), primary colorectal cancer in 4 (2.2%), and metastases to the rectum or sigmoid colon in 2 (1.1%) of patients were detected. Conclusion: Colonoscopy permits more excellent detection of colorectal lesions and may give surgeons some vital information about the spreading of gynecologic cancer, which may, in turn, alter the treatment modality.

PDF

___

1. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: A review. Cancer Biol Med 2017;14:9–32.
2. Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gyne- col Oncol 2004;93:87–91.
3. Sakakura C, Hagiwara A, Yamazaki J, Takagi T, Hosokawa K, Shimomu- ra K, et al. Management of postoperative follow-up and surgical treat- ment for Krukenberg tumor from colorectal cancers. Hepatogastroenter- ology 2004;51:1350–3.
4. Petru E, Pickel H, Heydarfadai M, Lahousen M, Haas J, Schaider H, et al. Nongenital cancers metastatic to the ovary. Gynecol Oncol 1992;44:83–6.
5. Kim DD, Park IJ, Kim HC, Yu CS, Kim JC. Ovarian metastases from col- orectal cancer: A clinicopathological analysis of 103 patients. Colorectal Dis 2009;11:32–8.
6. Young-Fadok TM, Wolff BG, Nivatvongs S, Metzger PP, Ilstrup DM. Pro- phylactic oophorectomy in colorectal carcinoma: Preliminary results of a randomized, prospective trial. Dis Colon Rectum 1998;41:277–83; dis- cussion 283–5.
7. Hanna NN, Cohen AM. Ovarian neoplasms in patients with colorectal cancer: Understanding the role of prophylactic oophorectomy. Clin Col- orectal Cancer 2004;3:215–22.
8. Viiala CH, Zimmerman M, Cullen DJ, Hoffman NE. Complication rates of colonoscopy in an Australian teaching hospital environment. Intern Med J 2003;33:355–9.
9. Rozen P, Fireman Z, Figer A, Ron E. Colorectal tumor screening in wom- en with a past history of breast, uterine, or ovarian malignancies. Cancer 1986;57:1235–9.
10. Sorbi D, Schleck CD, Zinsmeister AR, Gostout CJ. Clinical application of a new colonoscope with variable insertion tube rigidity: A pilot study. Gastrointest Endosc 2001;53:638–42.
11. Patel SG, Ahnen DJ. Colorectal cancer in the young. Curr Gastroenterol Rep 2018;20:15.
12. Lindell LK, Anderson B. Routine pretreatment evaluation of patients with gynecologic cancer. Obstet Gynecol 1987;69:242–6.
13. Raś R, Barnaś E, Magierło JS, Drozdzowska A, Bartosiewicz E, Sobolewski M, et al. Preoperative colonoscopy in patients with a sup- posed primary ovarian cancer. Medicine (Baltimore) 2019;98:e14929.
14. Winawer SJ, Schottenfeld D, Flehinger BJ. Colorectal cancer screening. J Natl Cancer Inst 1991;83:243–53.
15. Levin B. Colorectal cancer screening. Cancer 1993;72:1056–60.
16. Fleischer DE, Goldberg SB, Browning TH, Cooper JN, Friedman E, Goldner FH, et al. Detection and surveillance of colorectal cancer. JAMA 1989;261:580–5.
17. Morson BC, Bussey HJ. Magnitude of risk for cancer in patients with colorectal adenomas. Br J Surg 1985;72:S23–5.
18. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol 2010;177:1053–64